Skip to main content

3-HO-PCE Facts

Dissociative; Arylcyclohexylamine; NMDA receptor antagonist

Description

3-HO-PCE (3-hydroxyeticyclidine) is a synthetic dissociative of the arylcyclohexylamine class. It blocks glutamate signaling and simultaneously activates opioid receptors, producing dissociative detachment layered with warmth and analgesia.[1][2]

Subjective effects include dissociation, pain suppression, euphoria, bodily warmth, sedation, and cognitive disconnection. The experience is warmer and more euphoric than ketamine — the opioid layer adds a physical glow absent from most dissociatives.

3-HO-PCE carries meaningful physical dependence risk, and the toxic dose is completely unknown.safety citation needed The opioid component means combining it with other depressants can suppress breathing through two mechanisms at once — and standard drug tests will not identify it in an emergency.[3]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 5 mgLight5 – 10 mgCommon10 – 15 mgStrong15 – 25 mgHeavy25+ mg

Starts in 15 – 30 minLasts 4 – 6 hoursAfter-effects 2 – 6 hours

Body and dependence

Acute toxicity
Moderate
Chronic toxicity
Moderate
Physical dependence
Moderate
Psychological dependence
Moderate
Withdrawal
Mild
Compulsive redosing
High

Tolerance

Builds
Moderate
Fully resets after
10.5 days
Carries over to
ketamine; PCP; DXM; MXE; 3-HO-PCP; 3-MeO-PCE; O-PCE; nitrous oxide

Effectslikely at a common dose

Perception
none likely · 36 possible, including Vestibular distortion, Spatial disorientation, Visual haze / noise
Body
Nystagmus (eye wobbles); Sedation; Pain suppression; Motor control impairment; +30 possible, including Dizziness, Dehydration sensation, Nausea
Thinking
Cognitive impairment; +29 possible, including Confusion, Decision impairment, Information processing suppression
Feeling
none likely · 9 possible, including Paranoia, Anxiety, Depression
Self
none likely · 10 possible, including Depersonalization, Derealization, Communication suppression
Time
none likely · 3 possible, including Temporal disorientation

Who shouldn't take it

Absolute
Respiratory compromise (COPD, sleep apnea); History of psychosis or schizophrenia; Pregnancy; Concurrent opioid use; Concurrent CNS depressant use (benzodiazepines, alcohol, GHB)
Relative
Cardiovascular disease; Seizure disorders; Hepatic impairment; Renal impairment

Combinations60 recorded

Lethal (4)
Benzodiazepines, Barbiturates; GHB, Baclofen; GHB, GBL; Local anesthetics
Dangerous (34)
Alpha-2 adrenergic receptor antagonist; Amphetamines; Benzodiazepines; Buprenorphine, Kratom; Cannabis, THC; Gabapentin, Pregabalin; MDMA, Amphetamines; Naltrexone; NRIs; NSAIDs; Stimulants; THC; Anticholinergics; Antihistamines; Atypical antipsychotics; Buspirone; Caffeine; CBD; Clonidine, Guanfacine; Dopamine agonists; Glutamate modulator; Huperzine A; Ibogaine; Ketamine, DXM, PCP; and 10 more, see full page
Caution (18)
See full page: psychedex.org/substances/3-ho-pce
Not graded (4)
Not listed never means safe.

Seek help immediately if

  • Severe disorientation; unable to move or speak (deep dissociation / "k-hole")
  • Complete loss of coordination — cannot stand or walk safely
  • Vomiting while incapacitated (choking / aspiration risk)
  • Very high blood pressure; fast heart rate
  • Slow or shallow breathing at high doses (especially mixed with depressants)
  • Unconsciousness; rarely, seizures

What to do

  1. Move them somewhere safe, away from stairs, water, roads, and sharp edges — they cannot protect themselves
  2. Place in the recovery position if vomiting or unconscious (aspiration is a key risk)
  3. Stay with them and reassure calmly; keep the environment quiet
  4. If breathing is slow/shallow or they are unresponsive, call emergency services
  5. Do not let them wander; do not leave them alone
  6. Be ready to give rescue breaths / CPR

Effects wear off with time in a safe, monitored setting. The main dangers are physical injury and aspiration while incapacitated, and respiratory depression when combined with other depressants — not the dissociation itself.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Martin D, Lodge D (1988) Phencyclidine receptors and N-methyl-D-aspartate antagonism: electrophysiologic data correlates with known behaviours — Pharmacology, Biochemistry and Behavior PMID:2854262
  2. [2]
    ^Itzhak Y, Kalir A, Sarne Y (1981) On the opioid nature of phencyclidine and its 3-hydroxy derivative — European Journal of Pharmacology doi:10.1016/0014-2999(81)90097-2
  3. [3]
    ^Gicquel T, Richeval C, Mesli V, Gish A, Hakim F, Pelletier R, Cornez R, Balgairies A, Allorge D, Gaulier JM (2021) Fatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE) — Forensic Science International doi:10.1016/j.forsciint.2021.110852
Print version
Report an issue